Carlisle agreed to acquire Providien, a provider of comprehensive manufacturing solutions for global medical device OEMs, including: thermoforming, medical device contract manufacturing, precision machining & metals, and medical injection molding. The transaction is subject to customary closing conditions and is expected to close in the fourth quarter of 2019. Financial terms were not disclosed. “The acquisition of Providien fits our Medical Technologies platform expansion and vertical integration strategy, driven by aging populations and increased preference for minimally invasive surgical procedures. Providien adds new products for medical markets, including: Robotics, Drug Delivery, Oncology, and Kyphoplasty, currently not served by CIT's product portfolio," Chris Koch, Carlisle President and Chief Executive Officer.